Skip to content
Recall Observatory FDA recall evidence

Drug product

Olanzapine Tablets, 2.5 mg, 1000-count bottles, Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India, NDC 62756-551-18.

D-0699-2017

March 22, 2017

Class III

Product summary

Firm
Sun Pharmaceutical Industries, Inc.
Event
Event 76819
Status
Terminated
Classification
Class III
Quantity
60 bottles
Official record key
drug-enforcement:D-0699-2017

Official wording

Reason: Failed Impurities/Degradation Specifications: out of specification results for the related substances test parameter (impurities).

Code information: Lot #: JKP2751A, Exp 05/17; JKR5048A, Exp 04/18

Distribution pattern: Nationwide in the USA and Puerto Rico

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    out of specification